Jinfo BlogInsights and updates for pharmaceutical companies

Tuesday, 15th August 2017 Sign in to MyJinfo or create an account be able to star items Click for printable version Subscribe via RSS to get updates as soon as Blog items are added Tweet about this item on Twitter Share on Facebook Share on LinkedIn

By Catherine Dhanjal

« Blog


Find out what Jinfo offers Subscribers in biopharma, life sciences and the STM field.


Mergers and acquisitions, major drug patent expiries and an average drug development time of 10 to 15 years are leading to shrinking information centres and increased expectation of end user research.

However, conversely, current awareness and specialised industry research is the cornerstone of new drug development, potentially helping to drastically reduce the cost of drug development and its speed to market.

If information teams can redefine themselves as experts at the more complex and strategic end of their organisations' research needs they should be assured of their place for many years to come. 

What is it that pharma info teams get from Jinfo?

Jinfo's customers in the pharmaceutical, life sciences and STM sectors benefit from access to specific coverage of sources and technology products directly related to areas such as discovery, patents, visualisation tools and pharma content products. 

On top of that is the value piece - access to strategic articles and reports helping those responsible for managing and developing information services to take their teams forward. This includes our recent original research where we shed unique light on information services and provided the data, analysis and models to empower our customers to benchmark their own services against a competitor set. 

Here's just a sample of the original research, market landscapes, product reviews and articles available to Jinfo Subscribers:


Find out more in our free pharma-focused events this month: 


Join a pharma-focused walkthrough of Jinfo, including a short presentation on our benchmarking research and how you can use it now to lay the groundwork for 2018. We'll also highlight our articles, reports and webinars of interest to organisations in the pharmaceutical sector in areas from specialist content sources to patent databases and our research into discovery solutions.

This event is open to Jinfo customers and prospects: Monday 21st August, 16:00 - 16:30 (BST)

Request more information and register by contacting Catherine Dhanjal, head of content, catherine.dhanjal@jinfo.com


Some of the best insights come from peers. Join us at an upcoming Community session - the BioPharma Roundtable - and experience for yourself the special value of these private, confidential sessions.

This event is open to Jinfo customers at any level of subscription: Wednesday 23rd August, 16:00 - 17:00 (BST)

Request more information and register by contacting Amy Burns, head of community, amy.burns@jinfo.com


Jinfo works with a number of pharma companies to consult on department optimisation, strategic planning, and stakeholder engagement. To learn more, contact Robin Neidorf, director of research and head of consulting, robin.neidorf@jinfo.com

« Blog

Benefit from our research

Content and Community

Connect your team with the practical tools, original research and expertise to build and support information strategy in your organisation.

A Jinfo Subscription gives access to all Content (articles, reports, webinars) and Community.

Subscription benefits


Our proven processes, resources and guidance will help your team make the shift from transaction centre to strategic asset.

Read case studies, and start the conversation.

Consulting benefits